John Fair - 24 Jan 2023 Form 4 Insider Report for Dare Bioscience, Inc. (DARE)

Role
Chief Commercial Officer
Signature
/s/ John Fair
Issuer symbol
DARE
Transactions as of
24 Jan 2023
Transactions value $
$0
Form type
4
Filing time
26 Jan 2023, 15:05:36 UTC
Previous filing
28 Jan 2022
Next filing
14 Mar 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DARE Stock Option (right to buy) Award $0 +290,000 $0 290,000 24 Jan 2023 Common stock 290,000 $1.16 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This stock option vests and becomes exercisable in 48 equal monthly installments commencing on the one-month anniversary of the grant date, subject to the reporting person's continuous service to the issuer.